Price movement over the last 24 hours
ACADIA Pharmaceuticals Inc. vs Archer-Daniels-Midland Co — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while Archer-Daniels-Midland Co trades at $80.4 (market cap $37.69B). The key difference: Archer-Daniels-Midland Co is far larger — about 8.4× ACADIA Pharmaceuticals Inc.'s market cap, and Archer-Daniels-Midland Co pays a 2.66% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | ADM | |
|---|---|---|
Market Cap | $4.49B | $37.69B |
Sector | Health | Consumer Staples |
52-Week High | $28.06 | $84.11 |
52-Week Low | $20.06 | $53.54 |
Enterprise Value | $3.69B | $47.72B |
Dividend Yield | — | 2.66% |
Trailing returns across standard periods
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. Additionally, the company owns an extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients. The company is also a large producer of corn-based sweeteners, starches, and ethanol.
Read more on ADM →